Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Institute Hires GeneArt for Tailored Synthetic Genes

NEW YORK (GenomeWeb News) – GeneArt has received a contract from the UK’s Wellcome Trust Sanger Institute to synthesize as many as 600 tailor-made genes over the next ten months, which the institute will use to identify mechanisms involved in genetic and infectious diseases.
The Sanger Institute is currently expanding its program focused on identifying the novel human extracellular receptor-ligand interactions that may be involved in genetic diseases such as cardiovascular disease and infectious diseases. These studies will involve screening for interactions within protein libraries that make up the “cell surface repertoire of differentiated human blood cells, and also some pathogens,” Regensburg, Germany-based GeneArt said in a statement.
The institute also will use the protein libraries to determine the functional consequences of the identified interactions in cell-based assays.
Financial terms of the agreement were not released.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.